ANET vs. NBIX
ANET (Arista Networks, Inc.) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. ANET operates in Computer Hardware (Technology), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, ANET returned 43.12%/yr vs 13.16%/yr for NBIX. At a 0.25 correlation, their price movements are largely independent.
Performance
ANET vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANET achieves a 24.58% return, which is significantly higher than NBIX's 12.64% return. Over the past 10 years, ANET has outperformed NBIX with an annualized return of 43.12%, while NBIX has yielded a comparatively lower 13.16% annualized return.
ANET
- 1D
- 4.37%
- 1M
- 16.03%
- YTD
- 24.58%
- 6M
- 30.84%
- 1Y
- 70.45%
- 3Y*
- 57.04%
- 5Y*
- 48.31%
- 10Y*
- 43.12%
NBIX
- 1D
- -1.81%
- 1M
- -0.97%
- YTD
- 12.64%
- 6M
- 4.55%
- 1Y
- 27.80%
- 3Y*
- 18.64%
- 5Y*
- 10.13%
- 10Y*
- 13.16%
ANET vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ANET Arista Networks, Inc. | 24.58% | 18.55% | 87.73% | 94.07% | -15.58% | 97.89% | 42.86% | -3.46% | -10.56% | 143.44% |
NBIX Neurocrine Biosciences, Inc. | 12.64% | 3.90% | 3.60% | 10.31% | 40.24% | -11.14% | -10.83% | 50.53% | -7.96% | 100.49% |
Correlation
The correlation between ANET and NBIX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jun 6, 2014 | 0.25 |
The correlation between ANET and NBIX shifts across timeframes, from 0.09 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ANET:
$207.94B
NBIX:
$16.52B
ANET:
$2.92
NBIX:
$6.53
ANET:
55.91
NBIX:
24.46
ANET:
1.31
NBIX:
0.48
ANET:
21.42
NBIX:
5.27
ANET:
15.42
NBIX:
4.85
ANET:
$9.71B
NBIX:
$3.10B
ANET:
$6.17B
NBIX:
$3.05B
ANET:
$4.21B
NBIX:
$881.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANET vs. NBIX — Risk / Return Rank
ANET
NBIX
ANET vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arista Networks, Inc. (ANET) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANET | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.43 | ||
| Sortino ratioReturn per unit of downside risk | +0.53 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.19 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 2.50 | 1.34 | +1.16 |
| Martin ratioReturn relative to average drawdown | 5.20 | 2.94 | +2.26 |
Loading charts...
Drawdowns
ANET vs. NBIX - Drawdown Comparison
The maximum ANET drawdown since its inception was -52.20%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for ANET and NBIX.
Loading charts...
Drawdown Indicators
| ANET | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.20% | -97.21% | +45.01% |
Max Drawdown (1Y)Largest decline over 1 year | -28.33% | -20.90% | -7.43% |
Max Drawdown (3Y)Largest decline over 3 years | -50.42% | -42.89% | -7.53% |
Max Drawdown (5Y)Largest decline over 5 years | -50.42% | -42.89% | -7.53% |
Max Drawdown (10Y)Largest decline over 10 years | -52.20% | -46.39% | -5.81% |
Current DrawdownCurrent decline from peak | -8.15% | -4.54% | -3.61% |
Average DrawdownAverage peak-to-trough decline | -15.39% | -43.84% | +28.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.60% | 9.49% | +4.11% |
Volatility
ANET vs. NBIX - Volatility Comparison
Arista Networks, Inc. (ANET) has a higher volatility of 16.62% compared to Neurocrine Biosciences, Inc. (NBIX) at 9.63%. This indicates that ANET's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANET | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.62% | 9.63% | +6.99% |
Volatility (6M)Calculated over the trailing 6-month period | 40.79% | 23.91% | +16.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.57% | 31.38% | +22.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.23% | 32.73% | +14.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.00% | 39.13% | +5.87% |
Dividends
ANET vs. NBIX - Dividend Comparison
Neither ANET nor NBIX has paid dividends to shareholders.
Financials
ANET vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Arista Networks, Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ANET vs. NBIX - Profitability Comparison
ANET - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported a gross profit of 1.68B and revenue of 2.71B. Therefore, the gross margin over that period was 61.9%.
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
ANET - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported an operating income of 1.16B and revenue of 2.71B, resulting in an operating margin of 42.7%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
ANET - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported a net income of 1.02B and revenue of 2.71B, resulting in a net margin of 37.8%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
Frequently Asked Questions
ANET and NBIX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANET has higher volatility (16.62%) compared to NBIX (9.63%). In terms of maximum drawdown, ANET dropped -52.20% vs NBIX's -97.21%.
ANET currently has the higher Sharpe Ratio (1.32 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANET and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer